PMC:7247521 / 46733-47856
Annnotations
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
849 | 50-58 | Disease | denotes | COVID-19 | MESH:C000657245 |
850 | 269-273 | Disease | denotes | SARS | MESH:D045169 |
851 | 319-327 | Disease | denotes | COVID-19 | MESH:C000657245 |
852 | 349-357 | Disease | denotes | COVID-19 | MESH:C000657245 |
853 | 398-406 | Disease | denotes | COVID-19 | MESH:C000657245 |
854 | 624-632 | Disease | denotes | COVID-19 | MESH:C000657245 |
855 | 729-737 | Disease | denotes | COVID-19 | MESH:C000657245 |
856 | 996-1004 | Disease | denotes | COVID-19 | MESH:C000657245 |
857 | 1103-1111 | Disease | denotes | COVID-19 | MESH:C000657245 |
LitCovid-PMC-OGER-BB
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T725 | 50-58 | SP_7 | denotes | COVID-19 |
T726 | 269-273 | SP_10 | denotes | SARS |
T727 | 319-327 | SP_7 | denotes | COVID-19 |
T728 | 349-357 | SP_7 | denotes | COVID-19 |
T729 | 398-406 | SP_7 | denotes | COVID-19 |
T730 | 552-564 | CHEBI:52217;CHEBI:52217 | denotes | pharmacology |
T731 | 624-632 | SP_7 | denotes | COVID-19 |
T732 | 729-737 | SP_7 | denotes | COVID-19 |
T733 | 935-941 | SO:0000276 | denotes | miRNAs |
T734 | 996-1004 | SP_7 | denotes | COVID-19 |
T735 | 1103-1111 | SP_7 | denotes | COVID-19 |
LitCovid-PD-FMA-UBERON
Id | Subject | Object | Predicate | Lexical cue | fma_id |
---|---|---|---|---|---|
T191 | 366-375 | Body_part | denotes | cytokines | http://purl.org/sig/ont/fma/fma84050 |
LitCovid-PD-MONDO
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T117 | 50-58 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T118 | 269-273 | Disease | denotes | SARS | http://purl.obolibrary.org/obo/MONDO_0005091 |
T119 | 319-327 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T120 | 349-357 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T121 | 398-406 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T122 | 624-632 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T123 | 729-737 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T124 | 996-1004 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T125 | 1103-1111 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
LitCovid-PD-CLO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T424 | 741-742 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T343 | 0-59 | Sentence | denotes | In summary, QFPD is effective in the treatment of COVID-19. |
T344 | 60-237 | Sentence | denotes | However, some shortcomings in our study include lack of an in-depth study of predictive monomers and key targets and pathways, thus need further validation in vivo and in vitro. |
T345 | 238-504 | Sentence | denotes | And the TCMATCOV platform uses SARS disease network, which is different from the COVID-19 disease network, and COVID-19-related cytokines are related to severe COVID-19 disease, so the results of platform analysis more reflect the potential efficacy of severe stage. |
T346 | 505-660 | Sentence | denotes | Nevertheless, this study confirms that network pharmacology can help explore the mechanism of QFPD on the treatment of COVID-19 with time- and cost-saving. |
T347 | 661-853 | Sentence | denotes | Moreover, based on our new FUNP analysis, we reveal that QFPD treat COVID-19 by a holistic treatment and multi-component synergy, and are further demonstrated by formula perturbation analysis. |
T348 | 854-1005 | Sentence | denotes | In addition, this study provides possible candidate monomers of QFPD and related miRNAs, kinases and TFs with potential therapeutic effect on COVID-19. |
T349 | 1006-1123 | Sentence | denotes | This will hopefully provide evidence and new insights for further researches on the treatment of COVID-19 using QFPD. |